Table 3.
Total (n = 1291) |
T (n = 691) |
HP (n = 199) |
LP (n = 371) |
||||||
---|---|---|---|---|---|---|---|---|---|
Antihypertensive medications (n, %) | 683 | 54.8% | 378 | 54.4% | 109 | 54.5% | 196 | 53.5% | |
Antihypotensive medications (n, %) | 3 | 0.2% | 1 | 0.1% | 1 | 0.5% | 1 | 0.3% | |
Medications with hypertensive side effects (n, %) | 215 | 17.7% | 94 | 13.6% | 34 | 16.3% | 87 | 23.4% | 2 |
Medications with hypotensive side effects (n, %) | 718 | 57.5% | 379 | 54.8% | 116 | 58.4% | 223 | 60.6% | |
Medications with bradycardic side effects (n, %) | 656 | 52.0% | 336 | 48.6% | 114 | 57.3% | 206 | 55.5% | 1,2 |
Medications with tachycardic side effects (n, %) | 685 | 54.3% | 362 | 52.4% | 103 | 51.8% | 220 | 59.3% | 2 |
1, T vs. HP; 2, T vs. LP; 3, HP vs. LP; P < 0.05.